カテゴリ： GlobalData, ドイツ, 企業調査

Siemens Healthcare GmbH-医療機器分野：企業M&A・提携分析

◆英語タイトル：Siemens Healthcare GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011686
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月13日
◆ページ数：95
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Siemens Healthcare GmbH d/b/a Siemens Healthineers, a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT and medical infrastructure solutions, laboratory diagnostics equipment, medical imaging equipment, point-of-care testing devices, medical accessories, OEM component and medical electronics solutions and refurbished systems for medical imaging and therapy. Its products and solutions are utilized in the areas including cardiology, neurology, oncology, surgery, women’s health, diabetes, infectious disease, urology, organ transplant, therapeutic drug monitoring and growth disorders, among others. The company operates in Europe, the Americas, Africa and Asia-Pacific. Siemens Healthineers is headquartered in Erlangen, Germany.

Siemens Healthcare GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Siemens Healthcare GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Siemens Healthcare GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Siemens Healthcare GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Siemens Healthcare GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
Siemens Healthcare GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Siemens Healthcare GmbH, Medical Equipment, Deal Details 14
Asset Purchase 14
Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare 14
Partnerships 15
Siemens Healthineers Enters into Licensing Agreement with Rice University 15
Siemens Healthcare Enters into Licensing Agreement with Saladax Biomedical 16
Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics 17
MagneMotion Enters Into Licensing Agreement With Siemens Healthcare Diagnostics 18
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 19
Siemens Healthcare Diagnostics Enters Into Licensing Agreement With Nephromics 20
Horiba and Siemens Healthineers Enter into Agreement 21
Houston Methodist Hospital and Siemens Healthineers Enter into Agreement 22
Siemens Healthcare Enters into Agreement with Imricor Medical 23
Siemens Healthcare Enters into Co-Development Agreement with Biogen 24
InSightec Enters into Partnership with Siemens Healthineers 25
Profound Medical Enters into Agreement with Siemens Healthcare 26
MRI Interventions Enters Into Co-Development Agreement With Siemens Medical Solutions 27
Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 29
Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 30
Siemens Enters Into Co-Development Agreement With Varian Medical For Imaging Products 31
CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions 32
Siemens Enters Into Technology Integration Agreement With Radimetrics For Radiation Tracking 33
Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 34
Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 35
Varian Medical Systems Enters Into Co-Marketing Agreement With Siemens Healthcare 36
Siemens Healthcare Enters Into Technology Integration Agreement With MAQUET For Hybrid OR 37
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare 38
Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 39
Axis-Shield Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 40
Siemens Healthcare Diagnostics Amends its Co-Development Agreement with Universal Biosensors 41
Siemens Enters Into Technology Integration Agreement With St. Jude Medical 42
Rhoen-Klinikum Enters Into Co-Development Agreement With Siemens 43
Siemens Healthcare Diagnostics Enters Into Co-Marketing Agreement With Bruker 44
Endosense Enters Into Co-Development Agreement With Siemens Healthcare 45
Stereotaxis Enters Into An Agreement With Siemens Healthcare 46
BG Medicine Enters Into An Agreement With Siemens Healthcare Diagnostics 47
Equity Offering 48
Siemens Healthcare May Raise up to USD47.3 Billion in IPO 48
Siemens Healthcare Postpones IPO of Shares 49
Asset Transactions 50
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 50
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 51
Eli Lilly Acquires Two Alzheimer’s Disease Imaging Agents From Siemens Medical Solutions 52
Threshold Pharma To Acquire Hypoxia PET Imaging Agent 18F-HX4 From Siemens Healthcare 53
InterSystems Acquires Siemens Health Services France From Siemens Healthcare 54
Acquisition 55
Siemens Healthineers Acquires Epocal from Alere 55
Siemens Healthcare Acquires Medicalis 56
Siemens Healthcare Acquires Conworx Technology 57
Siemens Healthcare Acquires NEO New Oncology 58
Siemens Healthcare To Acquire Penrith, Maker Of Ultrasound Imaging Systems 59
Siemens Healthcare Completes Acquisition Of MobileMD 60
Siemens Healthcare GmbH – Key Competitors 61
Siemens Healthcare GmbH – Key Employees 62
Siemens Healthcare GmbH – Locations And Subsidiaries 63
Head Office 63
Other Locations & Subsidiaries 63
Joint Venture 66
Recent Developments 67
Strategy And Business Planning 67
May 18, 2017: Siemens Healthineers Aligns with Relaymed to Seamlessly Deliver Point-of-Care Test Results to EHR Systems 67
Oct 12, 2016: Siemens Healthineers and IBM Watson Health forge global alliance for population health management 68
Legal and Regulatory 69
Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 69
Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers 70
May 04, 2016: Siemens Healthineers – The new brand for Siemens’ healthcare business 71
Government and Public Interest 72
Apr 28, 2017: Surgeons Perform World’s First-Ever Dual Robotic Surgery at Jerusalem’s Hadassah Hospital 72
Product News 73
Nov 26, 2017: Siemens Healthineers Strengthens CT Portfolio with Four New Systems 73
Oct 17, 2017: Siemens Healthineers Streamlines Protein Testing by Adding the Atellica NEPH 630 System to its Atellica Portfolio 75
Jun 12, 2017: Siemens Healthineers Showcases its Atellica Diagnostics Portfolio and POC Informatics Solutions at EuroMedLab 76
Feb 21, 2017: FDA Clears Compressed Sensing MRI Acceleration Technology From Siemens Healthineers 77
Nov 28, 2016: Global Partners Turn to Materialise to Revolutionize Patient Care 78
Oct 12, 2016: Siemens Healthineers and IBM Watson Health forge global alliance for population health management 79
Aug 15, 2016: New range of C-arms provides precision and enhanced productivity in the operating theatre 80
03/10/2016: Siemens Announces FDA Clearance for Cios Connect mobile C-arm in Cios Line 81
03/10/2016: Siemens Announces FDA Clearance for Cios Select mobile C-arm in Cios Line 82
02/29/2016: Siemens to Release Detection Test for Zika Virus 83
01/21/2016: Siemens Announces FDA Clearance of MAGNETOM Amira MRI Scanner 84
01/13/2016: FDA Clears Siemens’ New High-volume Coagulation Analyzer 85
Product Approvals 86
Mar 10, 2016: Siemens Announces FDA Clearance for Cios Connect mobile C-arm in Cios Line 86
Mar 10, 2016: Siemens Announces FDA Clearance for Cios Select mobile C-arm in Cios Line 87
Jan 21, 2016: Siemens Announces FDA Clearance of MAGNETOM Amira MRI Scanner 88
Jan 13, 2016: FDA Clears Siemens’ New High-volume Coagulation Analyzer 89
Other Significant Developments 90
Jun 27, 2017: New Hybrid Operating Room in Getinge Experience Center, Germany 90
May 10, 2017: Siemens Healthineers/Imricor Strategic Relationship Aims to Improve Procedures with MRI Scans of the Heart 91
Oct 28, 2016: SyntheticMR and Siemens Healthineers Sign Cooperation Agreement 92
Sep 14, 2016: Siemens introduces cloud-based network for imaging departments in the UK 93
Apr 25, 2016: Siemens Healthcare Enables the Exchange of Health Data with ELGA 94
Appendix 95
Methodology 95
About GlobalData 95
Contact Us 95
Disclaimer 95

List of Tables
Siemens Healthcare GmbH, Medical Equipment, Key Facts, 2016 2
Siemens Healthcare GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Siemens Healthcare GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Siemens Healthcare GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Siemens Healthcare GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Siemens Healthcare GmbH, Deals By Market, 2011 to YTD 2017 10
Siemens Healthcare GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare 14
Siemens Healthineers Enters into Licensing Agreement with Rice University 15
Siemens Healthcare Enters into Licensing Agreement with Saladax Biomedical 16
Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics 17
MagneMotion Enters Into Licensing Agreement With Siemens Healthcare Diagnostics 18
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 19
Siemens Healthcare Diagnostics Enters Into Licensing Agreement With Nephromics 20
Horiba and Siemens Healthineers Enter into Agreement 21
Houston Methodist Hospital and Siemens Healthineers Enter into Agreement 22
Siemens Healthcare Enters into Agreement with Imricor Medical 23
Siemens Healthcare Enters into Co-Development Agreement with Biogen 24
InSightec Enters into Partnership with Siemens Healthineers 25
Profound Medical Enters into Agreement with Siemens Healthcare 26
MRI Interventions Enters Into Co-Development Agreement With Siemens Medical Solutions 27
Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 29
Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 30
Siemens Enters Into Co-Development Agreement With Varian Medical For Imaging Products 31
CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions 32
Siemens Enters Into Technology Integration Agreement With Radimetrics For Radiation Tracking 33
Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 34
Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 35
Varian Medical Systems Enters Into Co-Marketing Agreement With Siemens Healthcare 36
Siemens Healthcare Enters Into Technology Integration Agreement With MAQUET For Hybrid OR 37
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare 38
Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 39
Axis-Shield Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 40
Siemens Healthcare Diagnostics Amends its Co-Development Agreement with Universal Biosensors 41
Siemens Enters Into Technology Integration Agreement With St. Jude Medical 42
Rhoen-Klinikum Enters Into Co-Development Agreement With Siemens 43
Siemens Healthcare Diagnostics Enters Into Co-Marketing Agreement With Bruker 44
Endosense Enters Into Co-Development Agreement With Siemens Healthcare 45
Stereotaxis Enters Into An Agreement With Siemens Healthcare 46
BG Medicine Enters Into An Agreement With Siemens Healthcare Diagnostics 47
Siemens Healthcare May Raise up to USD47.3 Billion in IPO 48
Siemens Healthcare Postpones IPO of Shares 49
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 50
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 51
Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions 52
Threshold Pharma To Acquire Hypoxia PET Imaging Agent 18F-HX4 From Siemens Healthcare 53
InterSystems Acquires Siemens Health Services France From Siemens Healthcare 54
Siemens Healthineers Acquires Epocal from Alere 55
Siemens Healthcare Acquires Medicalis 56
Siemens Healthcare Acquires Conworx Technology 57
Siemens Healthcare Acquires NEO New Oncology 58
Siemens Healthcare To Acquire Penrith, Maker Of Ultrasound Imaging Systems 59
Siemens Healthcare Completes Acquisition Of MobileMD 60
Siemens Healthcare GmbH, Key Competitors 61
Siemens Healthcare GmbH, Key Employees 62
Siemens Healthcare GmbH, Other Locations 63
Siemens Healthcare GmbH, Subsidiaries 65
Siemens Healthcare GmbH, Joint Venture 66

★海外企業調査レポート[Siemens Healthcare GmbH-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Kvaerner ASA (KVAER)：石油・ガス：M&Aディール及び事業提携情報
    Summary Kvaerner ASA (Kvaerner) is a provider of engineering, procurement and construction (EPC) services to steel substructures, topsides, concrete structures and onshore facilities. Its service portfolio includes project management, front-end engineering and design, detailed engineering, construct …
  • Unilever N.V.：戦略・SWOT・企業財務分析
    Unilever N.V. - Strategy, SWOT and Corporate Finance Report Summary Unilever N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Global Marine Systems Ltd-エネルギー分野：企業M&A・提携分析
    Summary Global Marine Systems Limited (Global Marine), a subsidiary of Bridgehouse Marine Limited, is a marine technology and engineering company. It provides submarine cable installation, maintenance and engineering services. Its capabilities include project management, subsea cable installation, s …
  • Kewpie Corporation：戦略・SWOT・企業財務分析
    Kewpie Corporation - Strategy, SWOT and Corporate Finance Report Summary Kewpie Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Digi International, Inc. (DGII)：企業の財務・戦略的SWOT分析
    Digi International, Inc. (DGII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BioAtla LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary BioAtla LLC (BioAtla) is a biotechnology company that develops novel monoclonal antibodies and other cell based therapeutics. The company utilizes proprietary conditionally active biologics and comprehensive integrated antibody optimization platforms to develop novel therapies. It develops d …
  • Fujifilm SonoSite Inc：企業の戦略的SWOT分析
    Fujifilm SonoSite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Tiscali Group：企業の戦略・SWOT・財務情報
    Tiscali Group - Strategy, SWOT and Corporate Finance Report Summary Tiscali Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL)：電力：M&Aディール及び事業提携情報
    Summary Fauji Fertilizer Bin Qasim Ltd (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural applicat …
  • Genomic Health Inc (GHDX)-製薬・医療分野：企業M&A・提携分析
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Rafael Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), a subsidiary of IDT Corp is a healthcare products provider that offers therapeutics. The company develops drug therapies for the treatment of cancer. It provides altered energy metabolism directed platform for cancer cell energy metabolism …
  • Odakyu Electric Railway Co Ltd (9007)：企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co Ltd (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Hofseth Biocare ASA：企業の戦略・SWOT・財務情報
    Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report Summary Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arup Group Ltd：企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Mirach Energy Ltd (AWO)：企業の財務・戦略的SWOT分析
    Summary Mirach Energy Ltd (Mirach Energy), formerly China Petrotech Holdings Ltd is a diversified company. The company operates through its business such as property and construction and oilfield services. Its oilfield services business offers enhanced oil recovery techniques and consultancy service …
  • Advanced Digital Broadcast SA：企業の戦略的SWOT分析
    Advanced Digital Broadcast SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Promedior Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Gridsum Holding, Inc. (GSUM)：企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cafe De Coral Holdings Limited：企業の戦略・SWOT・財務分析
    Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ultra Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Ultra Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Ultra Petroleum Corp (Ultra) is an independent upstream company, which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops long-life natural gas rese …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆